Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
33.00
+2.00
+6.45%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Final hours: unlock premium data with Claim 60% OFF
MGC Pharmaceuticals Ltd (MXCM)
London
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| MXC | Sydney | AUD | Delayed | |
| MGCLF | OTC Markets | USD | Delayed | |
| MXCM | London | GBP | Real-time |
Add to/Remove from a Portfolio
Add to Watchlist
- Volume: 4,260
- Bid/Ask: 0.00 / 0.00
- Day's Range: 29.00 - 33.00
MGC Pharma
33.00
+2.00
+6.45%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
MXCM Income Statement
Featured here, the Income Statement (earnings report) for MGC Pharmaceuticals Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
| Period Ending: | 2023 30/06 |
2023 31/03 |
2022 31/12 |
2022 30/09 |
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.362 | 0.362 | 1.33 | 1.33 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Cost of Revenue, Total | 0.336 | 0.336 | 0.715 | 0.715 | ||||||||||||||||||||||||||||||
| Gross Profit | 0.027 | 0.027 | 0.617 | 0.617 | ||||||||||||||||||||||||||||||
| Total Operating Expenses | 4.02 | 4.02 | 5.29 | 5.29 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Operating Income | -3.66 | -3.66 | -3.96 | -3.96 | ||||||||||||||||||||||||||||||
| Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
| Gain (Loss) on Sale of Assets | -0.694 | -0.694 | - | - | ||||||||||||||||||||||||||||||
| Other, Net | 2.07 | 2.07 | 1.57 | 1.57 | ||||||||||||||||||||||||||||||
| Net Income Before Taxes | -5.03 | -5.03 | -5.54 | -5.54 | ||||||||||||||||||||||||||||||
| Provision for Income Taxes | - | - | 0.001 | 0.001 | ||||||||||||||||||||||||||||||
| Net Income After Taxes | -5.03 | -5.03 | -5.54 | -5.54 | ||||||||||||||||||||||||||||||
| Minority Interest | -0.629 | -0.629 | -0.653 | -0.653 | ||||||||||||||||||||||||||||||
| Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
| U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income Before Extraordinary Items | -4.97 | -4.97 | -5.44 | -5.44 | ||||||||||||||||||||||||||||||
| Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income | -4.97 | -4.97 | -5.44 | -5.44 | ||||||||||||||||||||||||||||||
| Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
| Income Available to Common Excluding Extraordinary Items | -4.97 | -4.97 | -5.44 | -5.44 | ||||||||||||||||||||||||||||||
| Dilution Adjustment | 0.051 | 0.051 | - | - | ||||||||||||||||||||||||||||||
| Diluted Net Income | -5.02 | -5.02 | -5.44 | -5.44 | ||||||||||||||||||||||||||||||
| Diluted Weighted Average Shares | 3.3 | 3.3 | 2.59 | 2.59 | ||||||||||||||||||||||||||||||
| Diluted EPS Excluding Extraordinary Items | -1.52 | -1.52 | -2.1 | -2.1 | ||||||||||||||||||||||||||||||
| DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Normalized EPS | -0.802 | -0.802 | -0.919 | -0.919 | ||||||||||||||||||||||||||||||
* In Millions of AUD (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about MGC Pharmaceuticals Ltd
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Jack Argentum
Feb 28, 2021 4:30
Holding $MXC for along time.. now its finally turned the corner with the LSE listing and exposure to European investors, ive watched Roby & Team build this company to where it is today, Def one to watch!!! (Holding💪🤩)
2
3
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review